Fischer, Marco; Olbrich, Peter; Hadjadj, Jérôme; Aumann, Volker; Bakhtiar, Shahrzad; Barlogis, Vincent; Bloomfield, Markéta 
; Booth, Claire; Buddingh, Emmeline P.; Cagdas, Deniz; Castelle, Martin; Roxo Júnior, Pérsio ; Júnior, Pérsio Roxo
Source: Journal of Allergy and Clinical Immunology. Unidade: FMRP
Subjects: SÍNDROMES DE DEFICIÊNCIA IMUNOLÓGICA, INIBIDORES DE ENZIMAS, ESTUDOS PROSPECTIVOS, ESTUDOS RANDOMIZADOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FISCHER, Marco et al. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, v. 153, n. 1, p. 275-286.e18, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.jaci.2023.10.018. Acesso em: 01 maio 2026.APA
Fischer, M., Olbrich, P., Hadjadj, J., Aumann, V., Bakhtiar, S., Barlogis, V., et al. (2024). JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study. Journal of Allergy and Clinical Immunology, 153( 1), 275-286.e18. doi:10.1016/j.jaci.2023.10.018NLM
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, Bloomfield M, Booth C, Buddingh EP, Cagdas D, Castelle M, Roxo Júnior P, Júnior PR. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study [Internet]. Journal of Allergy and Clinical Immunology. 2024 ; 153( 1): 275-286.e18.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.jaci.2023.10.018Vancouver
Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, Bloomfield M, Booth C, Buddingh EP, Cagdas D, Castelle M, Roxo Júnior P, Júnior PR. JAK inhibitor treatment for inborn errors of JAK/STAT signalin: an ESID/EBMT-IEWP retrospective study [Internet]. Journal of Allergy and Clinical Immunology. 2024 ; 153( 1): 275-286.e18.[citado 2026 maio 01 ] Available from: https://doi.org/10.1016/j.jaci.2023.10.018
